Natural Products Targeting Metabolic Disorders in Diabetic Kidney Disease: Mechanisms and Therapeutic Perspectives

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes. Although the emergence of new therapies such as SGLT2 inhibitors, GLP-1 receptor agonists, aldosterone receptor antagonists, and endothelin receptor antagonists (ERAs) has expanded the therapeutic options for DKD, these therapies remain insufficient to meet the urgent clinical needs of contemporary society. Recent studies indicate that the pathogenesis of DKD involves multiple signaling pathways and drug targets. DKD is closely linked to the dysregulation of glucose, lipid, and amino acid metabolism. Compared to synthetic drugs, natural products offer advantages such as broader biological activities, favorable drug-like potential, multi-target mechanisms of action, enhanced safety and tolerability profiles, as well as abundant and renewable sources. Over the past two decades, natural products have demonstrated considerable potential in preclinical DKD studies (triptolide, quercetin, berberine, baicalin, resveratrol, proanthocyanidin B2), and various natural compounds are now considered integral components of comprehensive DKD management strategies, despite their disadvantages of poor solubility and low bioavailability. This review focuses on the cellular and molecular mechanisms through which natural products alleviate DKD by targeting metabolic disorders, summarizes the contributions of nanodelivery systems in improving the bioavailability of natural products, and presents related challenges in clinical translation, aiming to provide new insights for DKD treatment.

Authors

Institutions

Publication Details

Journal
The American Journal of Chinese Medicine
Published
2026-11-20
DOI
https://doi.org/10.1142/s0192415x26500886
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Natural Products Targeting Metabolic Disorders in Diabetic Kidney Disease: Mechanisms and Therapeutic Perspectives

Jin‐Ling Huo, Wen-Jia Fu
3 links
The American Journal of Chinese Medicine
Chronic Kidney Disease and Diabetes
article

Natural Products Targeting Metabolic Disorders in Diabetic Kidney Disease: Mechanisms and Therapeutic Perspectives

Jin‐Ling Huo, Wen-Jia Fu
article en

Abstract

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes. Although the emergence of new therapies such as SGLT2 inhibitors, GLP-1 receptor agonists, aldosterone receptor antagonists, and endothelin receptor antagonists (ERAs) has expanded the therapeutic options for DKD, these therapies remain insufficient to meet the urgent clinical needs of contemporary society. Recent studies indicate that the pathogenesis of DKD involves multiple signaling pathways and drug targets. DKD is closely linked to the dysregulation of glucose, lipid, and amino acid metabolism. Compared to synthetic drugs, natural products offer advantages such as broader biological activities, favorable drug-like potential, multi-target mechanisms of action, enhanced safety and tolerability profiles, as well as abundant and renewable sources. Over the past two decades, natural products have demonstrated considerable potential in preclinical DKD studies (triptolide, quercetin, berberine, baicalin, resveratrol, proanthocyanidin B2), and various natural compounds are now considered integral components of comprehensive DKD management strategies, despite their disadvantages of poor solubility and low bioavailability. This review focuses on the cellular and molecular mechanisms through which natural products alleviate DKD by targeting metabolic disorders, summarizes the contributions of nanodelivery systems in improving the bioavailability of natural products, and presents related challenges in clinical translation, aiming to provide new insights for DKD treatment.

The American Journal of Chinese Medicine
Hainan General Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Hainan Medical University (CN)
Good health and well-being
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon